Normal ECG? You Could Still Be At Risk Of A Heart Attack, Why Tests Miss Warning Signs

Last Updated:April 21, 2026, 11:05 IST

A study, conducted by GB Pant Hospital, found that 80% of patients who suffered a first heart attack were not identified as high-risk by standard screening methods beforehand

Early-stage disease, mild plaque build-up, or unstable arterial conditions may not show up at all in ECG or stress tests.

A clean ECG. A “normal” stress test. A reassuring cholesterol report. For many, these results feel like a green signal. But modern cardiology is increasingly challenging this. The reality is that normal test results do not always mean a healthy heart.

A recent study, conducted by GB Pant Hospital in Delhi, found that 80% of patients who suffered a first heart attack were not identified as high-risk by standard screening methods beforehand.

In fact, some of the most dangerous cardiac conditions develop quietly, slipping past routine screening tools until they trigger a crisis.

What Routine Heart Tests Actually Measure

Most standard cardiac evaluations — electrocardiograms (ECG), treadmill stress tests, and basic blood panels — are designed to detect visible or advanced abnormalities. They assess electrical activity, blood flow under stress, or common markers like cholesterol.

These tests are useful, but they are not exhaustive. A stress test, for instance, typically identifies significant artery blockages, often those exceeding 70% narrowing.

“When a patient hears that his heart test is ‘normal’, it often brings reassurance. But in cardiology ‘normal’ does not always mean ‘risk-free’. Many routine tests, such as ECGs or basic stress tests, are designed to detect overt abnormalities. However, they may miss early-stage or silent conditions like microvascular disease, plaque instability, or intermittent arrhythmias that don’t show up during the test window,” said Dr Aniruddha Mandal, Cardiologist, BM Birla Heart Hospital.

What To Know About The Problem Of False Reassurance?

One of the biggest challenges in cardiac diagnostics is the concept of a “false negative”, when a test appears normal despite underlying disease.

Even widely used tools like ECGs have limitations. Studies suggest false-negative rates of around 10%, particularly when detecting structural conditions such as hypertrophic cardiomyopathy (HC) in young athletes. While ECGs are valuable for screening, this 10% rate means that a significant minority of asymptomatic individuals with pathologic conditions may have normal or non-pathologic ECG results, limiting the test’s reliability.

Similarly, cardiac stress tests are not designed to predict all types of cardiac events. Rather they are primarily designed to detect severely narrowed or blocked arteries. Many heart attacks are caused not by severe blockages, but by smaller plaques that rupture unexpectedly, conditions that routine tests often miss.

This creates a dangerous paradox in which patients may feel reassured by normal reports, even as silent risks continue to build.

Why Early Disease Often Goes Undetected

Heart disease does not always begin with obvious symptoms or large blockages. It often starts at a microscopic level within artery walls, where inflammation and plaque formation gradually develop.

“This is particularly concerning in today’s context, where younger individuals with no obvious risk factors are presenting with cardiac events. In such cases, relying solely on routine screenings can create a false sense of security,” said Dr Mandal.

Routine tests are not always equipped to detect these early changes. They focus on function — how the heart behaves under stress — rather than structure or vulnerability.

Research also shows that some diagnostic tools, such as exercise stress testing (EST), have relatively lower accuracy for detecting coronary artery disease (CAD) compared to more advanced imaging techniques. EST often has a sensitivity and specificity 63%-74% and is more useful for ruling out CAD rather than definitively confirming it. It often misses early signs of plaque build-up and can produce false positives, according to the American College of Cardiology.

However, Stress Echocardiography (SE) provides higher diagnostic accuracy than EST and is comparable to nuclear perfusion imaging, offering a better balance of sensitivity and specificity.

Stress Cardiovascular Magnetic Resonance (CMR) exhibits the highest diagnostic accuracy and sensitivity (up to 84.8% in some studies) compared to EST, SPECT, and stress echocardiography.

A 2015 study of 391 symptomatic patients, often cited by institutions like Johns Hopkins, confirms that non-invasive coronary CT angiography (CCTA) accurately identifies clogged arteries in 91% of patients, compared to only 69% for stress tests. CCTA, or ‘cardiac CTA’, is more sensitive at detecting anatomical stenosis (blockages) than stress tests, which mainly identify severe flow restrictions.

What Are The ‘Silent Risk’ Factors?

Another reason routine tests can miss danger is that they do not capture all risk factors. Traditional reports focus on cholesterol, blood pressure, and sugar levels. But newer research highlights additional markers such as genetic factors, inflammation, and specific lipoproteins that are not part of standard screening.

Some individuals with “normal” cholesterol levels still develop heart disease due to hidden markers like Lipoprotein(a), which can accelerate plaque build-up and clot formation.

Lifestyle-related issues such as chronic stress, poor sleep, sedentary habits, and hidden metabolic dysfunction, can quietly impact heart health without immediately altering standard test results, stressed Dr Mandal.

“Chronic stress elevates cortisol and promotes arterial inflammation, accelerating atherosclerosis. Poor sleep is independently linked to hypertension and arrhythmia risk. Sedentary behaviour reduces HDL cholesterol and promotes insulin resistance, both of which silently damage the vascular system over years before any test flags an abnormality,” he added.

When Symptoms Matter More Than Reports

A key shift in modern cardiology is the growing emphasis on a more nuanced and patient-centric approach that prioritises clinical judgment over isolated test results. This means patient-reported outcomes and comprehensive, and AI-assisted diagnostics. Thus, relying on instrumentation alone can cause clinicians to miss subtle signs of disease, such as coronary plaque in asymptomatic individuals.

Advanced diagnostics such as CT coronary angiography, cardiac MRI, or prolonged rhythm monitoring can uncover hidden threats that routine tests might overlook, Dr Mandal pointed out. “Equally important is listening to the patient’s symptoms; persistent fatigue, unexplained breathlessness, or atypical chest discomfort should never be ignored, even if initial reports appear normal. Preventive cardiology today is about going beyond numbers on a report. It is about integrating clinical judgment, detailed patient history, and appropriate use of advanced technology.”

Doctors increasingly stress that diagnostic tools are part of a broader evaluation, not definitive answers. A “normal” report must always be interpreted in the context of symptoms, family history, and overall risk profile. Ignoring symptoms based on a single reassuring test can delay diagnosis and treatment.

Why Follow-Up Testing Is Necessary

No single cardiac test can provide a complete picture. Each tool has strengths and limitations, and many are designed as screening or preliminary assessments rather than final diagnoses.

This is why follow-up testing is necessary because cardiac conditions are often progressive, meaning they change, worsen, or develop new complications over time without showing early symptoms.

Dr Mandal stressed that patients “must understand that ‘normal’ is not an endpoint, but a checkpoint”. Regular follow-ups, lifestyle correction, and timely escalation of investigations can make the difference between early detection and a life-threatening event.

For example, follow-up tests such as lipid profiles, echocardiograms, or ECGs are crucial to determine if medications, lifestyle changes, or procedures like stents are working as expected.

Conditions like coronary artery disease, heart failure, and arrhythmias can progress, requiring regular checks to see if plaque in the arteries is stable, growing, or shrinking.

Repeat imaging, such as a Coronary CT Angiography (CCTA), helps doctors see if existing plaque has stabilised, which helps determine if treatment needs to be intensified or if it can stay the same.

If lab results show that blood pressure or cholesterol levels are still not in an ideal range, or if the heart’s function has changed, doctors will use follow-up data to adjust medication dosages.

Medical science is also moving towards more integrated approaches, such as combining imaging, biomarkers, and even AI to improve detection. Emerging studies show that advanced analysis can identify hidden risk patterns even in ECGs that appear normal to the human eye. These deep learning techniques identify, with high accuracy, subclinical conditions and future risks that conventional electrocardiography cannot.

Why Is There A Need For Personalised Heart Risk Assessment?

The concept of heart health is evolving from a checklist of test results to a more personalised, risk-based model. A combination of factors, such as age, genetics, lifestyle, metabolic health, and environmental exposure are considered. The focus is no longer just on diagnosing disease, but on predicting and preventing it.

This shift is particularly important in countries like India, where 2.86 million people die annually of heart disease. Nearly 62% of all cardiovascular deaths in the country are premature, occurring between the ages of 40 and 69.

Reports suggest that hypertension, the primary driver of heart disease, was estimated to affect over 200 million individuals in 2025.

A 2026 report indicates a 13% increase in heart attacks among adults younger than 45 since 2020. A Lancet study further stresses that Indians develop heart disease nearly 10 years earlier than their Western counterparts.

What Patients Need To Understand

For individuals, the takeaway is not to distrust medical tests, but to understand their limits.

“Medical tests are not untrustworthy, they are limited by design. Standard tests are built to be accessible, fast, and cost-effective, calibrated to catch established disease rather than sub-clinical risk. The takeaway for patients is to ask whether your risk profile warrants advanced screening, report all symptoms even when tests appear normal, and treat a normal result as a prompt for continued vigilance, not a clean chit,” Dr Mandal added.

A report may fall within standard ranges, but the body’s underlying processes may tell a different story. Silent plaque, hidden genetic risks, and early-stage disease can exist beneath seemingly perfect numbers.

A recent study, conducted by GB Pant Hospital in Delhi, found that 80% of patients who suffered a first heart attack were not identified as high-risk by standard screening methods beforehand.

In fact, some of the most dangerous cardiac conditions develop quietly, slipping past routine screening tools until they trigger a crisis.

What Routine Heart Tests Actually Measure

Most standard cardiac evaluations — electrocardiograms (ECG), treadmill stress tests, and basic blood panels — are designed to detect visible or advanced abnormalities. They assess electrical activity, blood flow under stress, or common markers like cholesterol.

These tests are useful, but they are not exhaustive. A stress test, for instance, typically identifies significant artery blockages, often those exceeding 70% narrowing.

“When a patient hears that his heart test is ‘normal’, it often brings reassurance. But in cardiology ‘normal’ does not always mean ‘risk-free’. Many routine tests, such as ECGs or basic stress tests, are designed to detect overt abnormalities. However, they may miss early-stage or silent conditions like microvascular disease, plaque instability, or intermittent arrhythmias that don’t show up during the test window,” said Dr Aniruddha Mandal, Cardiologist, BM Birla Heart Hospital.

What To Know About The Problem Of False Reassurance?

One of the biggest challenges in cardiac diagnostics is the concept of a “false negative”, when a test appears normal despite underlying disease.

Even widely used tools like ECGs have limitations. Studies suggest false-negative rates of around 10%, particularly when detecting structural conditions such as hypertrophic cardiomyopathy (HC) in young athletes. While ECGs are valuable for screening, this 10% rate means that a significant minority of asymptomatic individuals with pathologic conditions may have normal or non-pathologic ECG results, limiting the test’s reliability.

Similarly, cardiac stress tests are not designed to predict all types of cardiac events. Rather they are primarily designed to detect severely narrowed or blocked arteries. Many heart attacks are caused not by severe blockages, but by smaller plaques that rupture unexpectedly, conditions that routine tests often miss.

This creates a dangerous paradox in which patients may feel reassured by normal reports, even as silent risks continue to build.

Why Early Disease Often Goes Undetected

Heart disease does not always begin with obvious symptoms or large blockages. It often starts at a microscopic level within artery walls, where inflammation and plaque formation gradually develop.

“This is particularly concerning in today’s context, where younger individuals with no obvious risk factors are presenting with cardiac events. In such cases, relying solely on routine screenings can create a false sense of security,” said Dr Mandal.

Routine tests are not always equipped to detect these early changes. They focus on function — how the heart behaves under stress — rather than structure or vulnerability.

Research also shows that some diagnostic tools, such as exercise stress testing (EST), have relatively lower accuracy for detecting coronary artery disease (CAD) compared to more advanced imaging techniques. EST often has a sensitivity and specificity 63%-74% and is more useful for ruling out CAD rather than definitively confirming it. It often misses early signs of plaque build-up and can produce false positives, according to the American College of Cardiology.

However, Stress Echocardiography (SE) provides higher diagnostic accuracy than EST and is comparable to nuclear perfusion imaging, offering a better balance of sensitivity and specificity.

Stress Cardiovascular Magnetic Resonance (CMR) exhibits the highest diagnostic accuracy and sensitivity (up to 84.8% in some studies) compared to EST, SPECT, and stress echocardiography.

A 2015 study of 391 symptomatic patients, often cited by institutions like Johns Hopkins, confirms that non-invasive coronary CT angiography (CCTA) accurately identifies clogged arteries in 91% of patients, compared to only 69% for stress tests. CCTA, or ‘cardiac CTA’, is more sensitive at detecting anatomical stenosis (blockages) than stress tests, which mainly identify severe flow restrictions.

What Are The ‘Silent Risk’ Factors?

Another reason routine tests can miss danger is that they do not capture all risk factors. Traditional reports focus on cholesterol, blood pressure, and sugar levels. But newer research highlights additional markers such as genetic factors, inflammation, and specific lipoproteins that are not part of standard screening.

Some individuals with “normal” cholesterol levels still develop heart disease due to hidden markers like Lipoprotein(a), which can accelerate plaque build-up and clot formation.

Lifestyle-related issues such as chronic stress, poor sleep, sedentary habits, and hidden metabolic dysfunction, can quietly impact heart health without immediately altering standard test results, stressed Dr Mandal.

“Chronic stress elevates cortisol and promotes arterial inflammation, accelerating atherosclerosis. Poor sleep is independently linked to hypertension and arrhythmia risk. Sedentary behaviour reduces HDL cholesterol and promotes insulin resistance, both of which silently damage the vascular system over years before any test flags an abnormality,” he added.

When Symptoms Matter More Than Reports

A key shift in modern cardiology is the growing emphasis on a more nuanced and patient-centric approach that prioritises clinical judgment over isolated test results. This means patient-reported outcomes and comprehensive, and AI-assisted diagnostics. Thus, relying on instrumentation alone can cause clinicians to miss subtle signs of disease, such as coronary plaque in asymptomatic individuals.

Advanced diagnostics such as CT coronary angiography, cardiac MRI, or prolonged rhythm monitoring can uncover hidden threats that routine tests might overlook, Dr Mandal pointed out. “Equally important is listening to the patient’s symptoms; persistent fatigue, unexplained breathlessness, or atypical chest discomfort should never be ignored, even if initial reports appear normal. Preventive cardiology today is about going beyond numbers on a report. It is about integrating clinical judgment, detailed patient history, and appropriate use of advanced technology.”

Doctors increasingly stress that diagnostic tools are part of a broader evaluation, not definitive answers. A “normal” report must always be interpreted in the context of symptoms, family history, and overall risk profile. Ignoring symptoms based on a single reassuring test can delay diagnosis and treatment.

Why Follow-Up Testing Is Necessary

No single cardiac test can provide a complete picture. Each tool has strengths and limitations, and many are designed as screening or preliminary assessments rather than final diagnoses.

This is why follow-up testing is necessary because cardiac conditions are often progressive, meaning they change, worsen, or develop new complications over time without showing early symptoms.

Dr Mandal stressed that patients “must understand that ‘normal’ is not an endpoint, but a checkpoint”. Regular follow-ups, lifestyle correction, and timely escalation of investigations can make the difference between early detection and a life-threatening event.

For example, follow-up tests such as lipid profiles, echocardiograms, or ECGs are crucial to determine if medications, lifestyle changes, or procedures like stents are working as expected.

Conditions like coronary artery disease, heart failure, and arrhythmias can progress, requiring regular checks to see if plaque in the arteries is stable, growing, or shrinking.

Repeat imaging, such as a Coronary CT Angiography (CCTA), helps doctors see if existing plaque has stabilised, which helps determine if treatment needs to be intensified or if it can stay the same.

If lab results show that blood pressure or cholesterol levels are still not in an ideal range, or if the heart’s function has changed, doctors will use follow-up data to adjust medication dosages.

Medical science is also moving towards more integrated approaches, such as combining imaging, biomarkers, and even AI to improve detection. Emerging studies show that advanced analysis can identify hidden risk patterns even in ECGs that appear normal to the human eye. These deep learning techniques identify, with high accuracy, subclinical conditions and future risks that conventional electrocardiography cannot.

Why Is There A Need For Personalised Heart Risk Assessment?

The concept of heart health is evolving from a checklist of test results to a more personalised, risk-based model. A combination of factors, such as age, genetics, lifestyle, metabolic health, and environmental exposure are considered. The focus is no longer just on diagnosing disease, but on predicting and preventing it.

This shift is particularly important in countries like India, where 2.86 million people die annually of heart disease. Nearly 62% of all cardiovascular deaths in the country are premature, occurring between the ages of 40 and 69.

Reports suggest that hypertension, the primary driver of heart disease, was estimated to affect over 200 million individuals in 2025.

A 2026 report indicates a 13% increase in heart attacks among adults younger than 45 since 2020. A Lancet study further stresses that Indians develop heart disease nearly 10 years earlier than their Western counterparts.

What Patients Need To Understand

For individuals, the takeaway is not to distrust medical tests, but to understand their limits.

“Medical tests are not untrustworthy, they are limited by design. Standard tests are built to be accessible, fast, and cost-effective, calibrated to catch established disease rather than sub-clinical risk. The takeaway for patients is to ask whether your risk profile warrants advanced screening, report all symptoms even when tests appear normal, and treat a normal result as a prompt for continued vigilance, not a clean chit,” Dr Mandal added.

A report may fall within standard ranges, but the body’s underlying processes may tell a different story. Silent plaque, hidden genetic risks, and early-stage disease can exist beneath seemingly perfect numbers.

Stay Ahead, Read Faster

Scan the QR code to download the News18 app and enjoy a seamless news experience anytime, anywhere.

login